(24/7 MARKET NEWS) – InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) was trading above $12, this morning, when the Company dropped an anvil on the back of the new shareholders’ heads, in the form of $9 million in direct registered and private placement offerings. The preferred investment option exercise price is $5.05 per share
InVivo has already dropped by more than half, at $5.98 3.68 million shares.
PEGY and FNGR could be next.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.